OSUR
ANALYST COVERAGE12 analysts
HOLD
+33.3%upside to target
Buy
433%
Hold
867%
4 Buy (33%)8 Hold (67%)0 Sell (0%)
Full report →
PRICE
Prev Close
2.95
Open
3.01
Day Range2.97 – 3.19
2.97
3.19
52W Range2.08 – 3.82
2.08
3.82
53% of range
VOLUME & SIZE
Avg Volume
530.6K
FUNDAMENTALS
P/E Ratio
-2.9x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.06
Market-like
TECHNICAL
RSI (14)
62
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 105 days
Aug 31
Key MetricsTTM
Market Cap$206.55M
Revenue TTM$113.02M
Net Income TTM-$75.07M
Free Cash Flow-$47.88M
Gross Margin41.0%
Operating Margin-64.6%
Net Margin-66.4%
Return on Equity-21.5%
Return on Assets-19.8%
Debt / Equity0.13
Current Ratio5.46
EPS TTM$-1.08

OSUR News

About

based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo

CEO
Douglas Michels
David A. RappaportSenior Vice President of Corporate Development, Strategy & Integration
Jason Michael PlagmanVice President of Investor Relations
Kenneth J. McGrathChief Financial Officer
Rafal IwasiowSample Management Solutions R&D & Chief Scientist
Stefano TaucerGeneral Counsel & Corporate Secretary
Zachary WertSenior Vice President of Global Operations
Amy SteigerwaltSenior Vice President of Human Resources
Carrie Eglinton MannerPresident, Chief Executive Officer & Director
Michele AnthonySenior Vice President, Chief Accounting Officer, Controller & Assistant Secretary
Karen DaviesDiagnostics R&D & Chief Technologist